We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.55%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$712B
AUM Growth
+$31.8B
Cap. Flow
+$2.48B
Cap. Flow %
0.35%
Top 10 Hldgs %
21.18%
Holding
2,600
New
72
Increased
1,394
Reduced
949
Closed
59

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$2.27B
2
LLY icon
Eli Lilly
LLY
+$1.64B
3
NVDA icon
NVIDIA
NVDA
+$1.59B
4
RHT
Red Hat Inc
RHT
+$1.55B
5
BKNG icon
Booking.com
BKNG
+$1.12B

Sector Composition

Rank Sector Weight
1 Technology 18.88%
2 Healthcare 16.96%
3 Financials 13.79%
4 Consumer Discretionary 13.57%
5 Industrials 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DS
2351
DELISTED
Drive Shack Inc.
DS
$255K ﹤0.01%
54,267
+100
+0.2% +$486
APAM icon
2352
Artisan Partners
APAM
$2.97B
$252K ﹤0.01%
9,168
+158
+2% +$4.21K
NNI icon
2353
Nelnet
NNI
$4.52B
$252K ﹤0.01%
4,262
+38
+0.9% +$2.23K
CAL icon
2354
Caleres
CAL
$455M
$251K ﹤0.01%
12,619
HTLD icon
2355
Heartland Express
HTLD
$950M
$251K ﹤0.01%
13,891
+137
+1% +$2.62K
GERN icon
2356
Geron
GERN
$1.01B
$247K ﹤0.01%
174,858
+400
+0.2% +$661
WKHS icon
2357
Workhorse Group
WKHS
$33.7M
$247K ﹤0.01%
28
AIZP
2358
DELISTED
Assurant, Inc. 6.50% Series D Mandatory Convertible Preferred Stock, $1.00 par value
AIZP
$247K ﹤0.01%
2,200
TRUE
2359
DELISTED
TrueCar
TRUE
$244K ﹤0.01%
44,706
+427
+1% +$2.62K
ZIXI
2360
DELISTED
Zix Corporation
ZIXI
$241K ﹤0.01%
26,506
+9,100
+52% +$79.2K
EVTC icon
2361
Evertec
EVTC
$1.82B
$240K ﹤0.01%
7,333
+140
+2% +$4.12K
AXAS
2362
DELISTED
Abraxas Petroleum Corp
AXAS
$239K ﹤0.01%
11,617
+15
+0.1% +$365
CYBE
2363
DELISTED
Cyberoptics Corp
CYBE
$237K ﹤0.01%
14,600
PTGX icon
2364
Protagonist Therapeutics
PTGX
$9.84B
$236K ﹤0.01%
19,486
+7,586
+64% +$83.9K
INFN
2365
DELISTED
Infinera Corporation Common Stock
INFN
$236K ﹤0.01%
81,217
+1,130
+1% +$4.25K
IPHS
2366
DELISTED
Innophos Holdings, Inc.
IPHS
$236K ﹤0.01%
8,121
+18
+0.2% +$539
VSTO
2367
DELISTED
Vista Outdoor Inc.
VSTO
$236K ﹤0.01%
26,521
+100
+0.4% +$857
OMN
2368
DELISTED
OMNOVA Solutions Inc.
OMN
$235K ﹤0.01%
37,692
+100
+0.3% +$668
CBL
2369
DELISTED
CBL& Associates Properties, Inc.
CBL
$234K ﹤0.01%
224,688
+500
+0.2% +$578
INAP
2370
DELISTED
Internap Corporation
INAP
$234K ﹤0.01%
77,675
-436
-0.6% -$1.55K
BBSI icon
2371
Barrett Business Services
BBSI
$756M
$233K ﹤0.01%
11,304
+40
+0.4% +$774
CTO
2372
CTO Realty Growth
CTO
$819M
$233K ﹤0.01%
14,357
+126
+0.9% +$2.06K
EWL icon
2373
iShares MSCI Switzerland ETF
EWL
$2.22B
$233K ﹤0.01%
+6,200
New +$225K
EARN
2374
Ellington Residential Mortgage REIT
EARN
$163M
$232K ﹤0.01%
21,602
EWA icon
2375
iShares MSCI Australia ETF
EWA
$1.46B
$232K ﹤0.01%
+10,300
New +$226K

Similar funds

T. Rowe Price Associates's Q2 2019 Portfolio in Review

As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
  • T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
  • T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
  • T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
  • T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
  • T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
  • T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.

Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.